Evidence map›Paper›PMID 37752151›Full record

ArticleNature communications2023

Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.

Magen E Francis, Ethan B Jansen, Anthony Yourkowski, Alaa Selim, Cynthia L Swan, Brian K MacPhee, Brittany Thivierge, Rachelle Buchanan, Kerry J Lavender, Joseph Darbellay and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Magen E FrancisVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.ORCID http://orcid.org/0000-0002-8339-2454
Ethan B JansenVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.ORCID http://orcid.org/0000-0002-7212-7487
Anthony YourkowskiVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.ORCID http://orcid.org/0009-0009-7994-6168
Alaa SelimVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Cynthia L SwanVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Brian K MacPheeVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Brittany ThiviergeVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Rachelle BuchananVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Kerry J LavenderDepartment of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, SK, Canada.ORCID http://orcid.org/0000-0002-5329-4546
Joseph DarbellayVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Matthew B RogersVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Jocelyne LewVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Volker GerdtsVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.
Darryl FalzaranoVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada.ORCID http://orcid.org/0000-0002-8805-8068
Danuta M SkowronskiBC Centre for Disease Control, Immunization Programs and Vaccine Preventable Diseases Service, Vancouver, BC, Canada.
Calvin SjaardaDepartment of Psychiatry, Queen's University, Kingston, ON, Canada.ORCID http://orcid.org/0000-0002-9787-1915
Alyson A KelvinVaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, SK, Canada. alyson.kelvin@usask.ca.ORCID http://orcid.org/0000-0003-0940-0847
University of Saskatchewan · CAQueen's University · CAUniversity of British Columbia · CA

Funding

CIHR CLV 179494-2022CIHR GA2-177714CIHR OV5-170349CIHR PPE - 185823CIHR VRI-173022CIHR VS1-175531
6 · The paper itself

Abstract

SARS-CoV-2 variants and seasonal coronaviruses continue to cause disease and coronaviruses in the animal reservoir pose a constant spillover threat. Importantly, understanding of how previous infection may influence future exposures, especially in the context of seasonal coronaviruses and SARS-CoV-2 variants, is still limited. Here we adopted a step-wise experimental approach to examine the primary immune response and subsequent immune recall toward antigenically distinct coronaviruses using male Syrian hamsters. Hamsters were initially inoculated with seasonal coronaviruses (HCoV-NL63, HCoV-229E, or HCoV-OC43), or SARS-CoV-2 pango B lineage virus, then challenged with SARS-CoV-2 pango B lineage virus, or SARS-CoV-2 variants Beta or Omicron. Although infection with seasonal coronaviruses offered little protection against SARS-CoV-2 challenge, HCoV-NL63-infected animals had an increase of the previously elicited HCoV-NL63-specific neutralizing antibodies during challenge with SARS-CoV-2. On the other hand, primary infection with HCoV-OC43 induced distinct T cell gene signatures. Gene expression profiling indicated interferon responses and germinal center reactions to be induced during more similar primary infection-challenge combinations while signatures of increased inflammation as well as suppression of the antiviral response were observed following antigenically distant viral challenges. This work characterizes and analyzes seasonal coronaviruses effect on SARS-CoV-2 secondary infection and the findings are important for pan-coronavirus vaccine design.

Indexed as

Coronavirus NL63, HumanCOVID-19AnimalsCOVID-19 VaccinesCricetinaeHumansMaleMesocricetusSARS-CoV-2SeasonsCOVID-19 Vaccines

Identifiers

PMID37752151
PMCPMC10522707
OpenAlexW4387059807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.